Optimer Teams With AztraZeneca To Bring Dificid To South America
This article was originally published in PharmAsia News
Executive Summary
Optimer has signed a string of partnerships to commercialize the antibiotic around the world; the latest is with AstraZeneca, which will market the drug in South America, Central America, Mexico and the Caribbean.